Novo Nordisk shares gain 4.5% on fourth-quarter profit beat, Wegovy sales jump
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk rose 4.5% on Wednesday after reporting better-than-expected net profit in the fourth quarter amid soaring demand for its Wegovy obesity drugs, but forecast a slight slowdown in sales…